These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3316964)

  • 1. [Current status of pathobiochemistry and clinico-chemical laboratory diagnosis of liver fibrosis].
    Gressner AM
    Med Klin (Munich); 1987 Oct; 82(20):700-10. PubMed ID: 3316964
    [No Abstract]   [Full Text] [Related]  

  • 2. Liver extracellular matrix in health and disease.
    Bedossa P; Paradis V
    J Pathol; 2003 Jul; 200(4):504-15. PubMed ID: 12845618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-invasive diagnosis and monitoring of liver fibrosis and cirrhosis.
    Denzer UW; Lüth S
    Best Pract Res Clin Gastroenterol; 2009; 23(3):453-60. PubMed ID: 19505671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Liver fibrosis].
    Chevallier M; Paradis V; Bedossa P
    Ann Pathol; 1995; 15(5):372-9. PubMed ID: 8540923
    [No Abstract]   [Full Text] [Related]  

  • 5. [Fibronectin--a key substance in pathogenesis of liver cirrhosis?].
    Roeb E; Matern S
    Leber Magen Darm; 1993 Dec; 23(6):239-42. PubMed ID: 8309339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Current findings in hepatic fibrogenesis].
    Chira O
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1990; 42(2):111-8. PubMed ID: 1982185
    [No Abstract]   [Full Text] [Related]  

  • 7. Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies.
    Friedman SL
    N Engl J Med; 1993 Jun; 328(25):1828-35. PubMed ID: 8502273
    [No Abstract]   [Full Text] [Related]  

  • 8. Biomarkers of liver fibrosis: clinical translation of molecular pathogenesis or based on liver-dependent malfunction tests.
    Gressner OA; Weiskirchen R; Gressner AM
    Clin Chim Acta; 2007 Jun; 381(2):107-13. PubMed ID: 17399697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell interactions with the extracellular matrix.
    Bruckner-Tuderman L; von der Mark K; Pihlajaniemi T; Unsicker K
    Cell Tissue Res; 2010 Jan; 339(1):1-5. PubMed ID: 19902257
    [No Abstract]   [Full Text] [Related]  

  • 10. Genesis of hepatic fibrosis and its biochemical markers.
    Das SK; Vasudevan DM
    Scand J Clin Lab Invest; 2008; 68(4):260-9. PubMed ID: 18609066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Serologic diagnosis of liver fibrosis].
    Sauerbruch T
    Dtsch Med Wochenschr; 1999 Oct; 124(41):1191. PubMed ID: 10572514
    [No Abstract]   [Full Text] [Related]  

  • 12. Assessment of asymptomatic liver fibrosis in alcoholic patients using fibroscan: prospective comparison with seven non-invasive laboratory tests.
    Nguyen-Khac E; Chatelain D; Tramier B; Decrombecque C; Robert B; Joly JP; Brevet M; Grignon P; Lion S; Le Page L; Dupas JL
    Aliment Pharmacol Ther; 2008 Nov; 28(10):1188-98. PubMed ID: 18705692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic fibrosis: pathobiology and management.
    Kapoor D; Kumar N
    Trop Gastroenterol; 2000; 21(3):114-7. PubMed ID: 11084830
    [No Abstract]   [Full Text] [Related]  

  • 14. [Correlation between liver biopsy and liver function tests in the diagnosis of liver cirrhosis].
    Ohta Y; Ohkubo H; Hatori K; Shinomiya M
    Rinsho Byori; 1986 Jun; 34 Spec No 67():154-61. PubMed ID: 3773278
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hepatic fibrogenesis].
    Loréal O; Clément B; Deugnier Y
    Rev Prat; 1997 Mar; 47(5):482-6. PubMed ID: 9138408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-matrix interaction and hepatic fibrosis.
    Bissell DM
    Prog Liver Dis; 1990; 9():143-55. PubMed ID: 2156289
    [No Abstract]   [Full Text] [Related]  

  • 17. Cellular communications and cell-matrix interactions in the pathogenesis of fibroproliferative diseases: liver fibrosis as a paradigm.
    Gressner AM; Bachem MG
    Ann Biol Clin (Paris); 1994; 52(3):205-26. PubMed ID: 7998677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapeutical targets for revert liver fibrosis].
    García B L; Gálvez G J; Armendáriz B J
    Rev Med Chil; 2007 Jun; 135(6):783-91. PubMed ID: 17728907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The APRI may be enhanced by the use of the FIBROSpect II in the estimation of fibrosis in chronic hepatitis C.
    Snyder N; Nguyen A; Gajula L; Soloway R; Xiao SY; Lau DT; Petersen J
    Clin Chim Acta; 2007 Jun; 381(2):119-23. PubMed ID: 17442291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pathobiochemistry and clinicochemical diagnosis of liver fibrosis].
    Gressner AM
    Med Welt; 1980 Jan; 31(1):11-6. PubMed ID: 7382798
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.